2019
DOI: 10.3390/ijerph16173066
|View full text |Cite
|
Sign up to set email alerts
|

Managing Medication Cost Burden: A Qualitative Study Exploring Experiences of People with Disabilities in Canada

Abstract: Despite the abundant literature on the burden of rising costs of prescription medications, there is limited research to explore how these costs affect people and the decisions they are forced to make within the context of disability. In this qualitative study we explored strategies adopted, factors influencing, and the impact of some of these strategies to manage the burden of medication cost among persons with disabilities. We interviewed 12 adults with spinal cord injuries living in Canada, using a general i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
6
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(7 citation statements)
references
References 29 publications
1
6
0
Order By: Relevance
“…Two of our studies suggested that participants reported increased health care utilization as a result of their CRNA, but did not actually measure clinical outcomes or healthcare utilization. (46,57) The sole RCT in our SR found that the free provision and delivery of essential medications increased adherence by 10% and improved one of three clinical surrogates at 12 months follow-up, but did not improve clinical outcomes. (58) In summary, the relationship between medication costs, medication adherence and patient outcomes is more complex than originally thought.…”
Section: Discussionmentioning
confidence: 84%
“…Two of our studies suggested that participants reported increased health care utilization as a result of their CRNA, but did not actually measure clinical outcomes or healthcare utilization. (46,57) The sole RCT in our SR found that the free provision and delivery of essential medications increased adherence by 10% and improved one of three clinical surrogates at 12 months follow-up, but did not improve clinical outcomes. (58) In summary, the relationship between medication costs, medication adherence and patient outcomes is more complex than originally thought.…”
Section: Discussionmentioning
confidence: 84%
“…The cost of drugs modifies the choices made at all levels, from the stage of formulary management in the hospital to a physician deciding on a drug for a particular patient based on his financial condition and the indication to ensure better compliance and complete recovery. It is important to ensure that drugs are priced correctly to ensure that patients do not face a lot of burden because of medicines [ 7 , 8 ], and also ensure that different brands for a particular combination of drugs do not differ much in price so that the patients can choose between the brands based on their availability if the efficacy and bioavailability remain the same [ 9 ].…”
Section: Discussionmentioning
confidence: 99%
“…Studies have linked higher medical costs that is largely borne by out-of-pocket expenditure to impede health care access [82][83][84]. Having health insurance lowers the chance of failure to seek treatment due to prohibitive transport cost in a UHC implementing County.…”
Section: Discussionmentioning
confidence: 99%